Allergic diseases and their correlation with fungi;Choroby alergiczne i ich zwia̧zek z grzybami chorobotwórczymi

Mikologia Lekarska

Volumn 14, Issue 4, 2007, Pages 271-275

  Galȩba, Anna ^a   Zawirska, Agnieszka ^a   Adamski, Zygmunt ^a  

^a Zakład Mikologii Lekarskiej I Dermatologii AM W Poznaniu ^*  (Poland)

Author keywords

Allergic diseases; Clinical research; Diagnostics; Fungi; Prophylaxis

Indexed keywords

ALLERGEN; ANTIFUNGAL AGENT;

ALLERGIC CONJUNCTIVITIS; ALLERGIC RHINITIS; ALLERGY; ASPERGILLUS; ASTHMA; ATOPIC DERMATITIS; CANDIDA; FUNGUS; FUNGUS SPORE; HUMAN; MALASSEZIA; PENICILLIUM; PROPHYLAXIS; REVIEW; SINUSITIS; YEAST;

ASCOMYCOTA; ASPERGILLUS; BASIDIOMYCOTA; CANDIDA; FUNGI; MALASSEZIA; PENICILLIUM; ZYGOMYCETES;

EID: 38349045128     PISSN: 1232986X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. Broberg A., Faergemann J., Johansson S., Johasson S.G.O., Strarmegard I.L., Svejgaard E.: Pityrosporum ovale and atopic dermatitis in chidren and young adults. Acta Dermato-Venereol., 1992, 72, 187-192.
2. Gliński W., Rudzki E.: Alergologia dla lekarzy dermatologów. Czelej, Lublin, 2002, 21, 411-466.
3. Kaczmarek J., Bocheńska-Marciniak M.: Grzyby i ich udział w chorobach alergicznych. Terapia Alergologia, 2002, 119, 47-53.
4. Keiffer M., Bergbrant I.M., Faergemann J.: Immune reactions to Pityrosporum ovale in adult patients with atopic dermatitis and seborrhoeic dermatitis. J. Am. Acad. Dermatol., 1990, 22, 739-742.
5. Kimura M., Tsuruta S., Yoshida T.: IFN-gamma plays a dominant role in upregulation of Candida-specific IgE synthesis in patients with atopic dermatitis. Int. Arch. Allergy Immunol., 2000, 3, 195-199.
6. Kimura M., Tsuruta S., Yoshida T.: Measurement of Candida-specific lymphocyte proliferation by flow cytometry in children with atopic dermatitis. Arerugi, 1998, 4, 449-456.
7. Kimura M., Tsuruta S., Yoshida T.: Differences in cytokine by peripheral blood monuclear cells (PBMC) between patients with atopic dermatitis and bronchial astma. Clin. Exp. Immunol., 1999, 118, 192-196.
8. Krasnowska M., Jankowska R.: Alergiczny nieżyt nosa wywołany przez inne niż pyłki alergeny inhalacyjne. [w:] Choroby alergiczne i astma. red. J. Małolepszy. Volumed, Wrocław, 1996, 537-539.
9. Kurzawa R., Dymek L.: Badania in vivo. [w:]: Zarys diagnostyki chorób alergicznych wieku rozwojowego. Bamar, 1996.
10. Morita E., Hide M., Yoneya Y.: An assessment of the role of Candida albicans antigen in atopic dermatitis. J. Dermatol., 1999, 5, 282-287.
11. Nermes M., Falth-Magnusson K., Savolainen J., Viander M., Bjorksten B.: A comparison of the development of antibody responses to the polysaccharide antigen (Candida albicans mannan) in atopic and healthy infants and children.
12. Peciak B.: Rola mikroorganizmów w AZS. Przegl. Dermatol., 1995, 82, 3, 263.
13. Rasool O., Zargari A., Almqvist J.: Cloning, characterisation and expresion of complete coding sequences of three IgE binding Malassezia furfur allergens, Mal f 7, Mal f 8 and Mal f 9. Eur. J. Biochem., 2000, 14, 4355-4361.
14. Scalabrin D.M.F., Bavbek S., Matthew B.S., Perzanowski B., Wilson B., Platts-Mills, and T.A.E., Wheatley L.M.: Use of specific IgE in assessing the relevance of fungal and dust mote allergens to atopic dermatitis: a comparison with asthmatic and non asthmatic control subjects. J. Allergy Clin. Immunol. 1999, 104, 1273-1279.
15. Stachowitz S.: Persistant annular ertythema of infancy associated with candida colonization. Clin. Exp. Dermatol., 2000, 5, 404-405.
16. Yasueda H., Hashida-Okado T., Saito A.: Identification and cloning of two novel allergens from the lipophilic yest, Malassezia furfur. Biochem. Biophys. Res. Commun., 1998, 2, 240-244.
17. Baran E.: Zarys mikologii lekarskiej. Volumed, Wrocław, 1998.
18. Ezeamuzie C.I., Al-Ali A., Khan M., Hijazi Z., Dowaisan A., Thomson MS., Georgi J.: IgE-mediated sensitization to mould allergens among patients with allergic respiratory diseases in a desert environment. Int. Arch. Allergy Immunol. 2000, 4, 300-307.
19. Halonen M., Stern D.A., Wright A.L., Taussing M., Martinez F.D.: Alternaria as a major allergen for asthma in children raised in a desert environment. Am. J. Respir. Crit. Care Med., 1997, 155, 1356-1361.
20. Niedoszytko M.: Alergia na grzyby, ocean czéstości wystȩpowania, możliwości diagnostyki i prewencji. Praca doktorska, Akademia Medyczna w Gdańsku, Wydział Lekarski, 2004.
21. O'Hollaren M.T., Yunginger I.W., Offord K.P., Somers M.J., O'Connel E.J., Ballard D.J.: Exposure to an aeroallergen as a possible precipitating factor in respiratory arrest in young patients with astma. N. Engl. J.Med., 1991, 324, 359-364.
22. Gourley D., Whisman B., Jorgensen N., Martin M., Reid M.: Allergic bipolaris sinusitis: Clinical and immunopathologic characteristics. J. Allergy Clin. Immunol., 1990, 85, 583-591.
23. Kontothanasi G., Moschovakis E., Tareras V., Delis A., Anagnoston E.: Determination of sensitivity to inhalant allergens in patient with allergic rhinitis in West Athens. Rhinology, 1995, 33, 234-235.
24. Ward G., Karlsson G., Rose G., Platts-Mills T.: Trichophyton astma-sensitisation of bronchi and upper airways to dermatophite antigen. Lancet, 1989, 1, 859-862.
25. Wilken-Jensen K., Gravesen S.: Atlas of moulds in Europe. ASK Publ., Copenhagen, 1984.
26. Bogacka E., Matkowski K.: Wpływ grzybów na zdrowie ludzi. Mikol. Lek., 2001, 8, 175-178.
27. Katzenstein A.A., Sale S.R., Greenberger P.A.: Allergic Aspergillus sinusitis: a newly ecognized form of sinusitis. J. Allergy Clin. Immunol., 1983, 72, 89-93.
28. Leser Ch., Kauffman H., Virchow Ch., Menz G.: Specific serum immunopatterns in clinical phases of allergic bronchopulmonary aspergillosis. J. Allergy Clin. Immunol., 1992, 90, 589-599.
29. Seebacher C.: Candida in dermatology. Mycoses, 1999, 42, Suppl., 63-67.
30. Syed H., Arshad M.D.: Rola alergenów wystȩpuja̧ cych w pomieszczeniach zamkniȩtych w rozwoju alergii i astmy. Medycyna po Dyplomie, 2003, 4, 99-109.
31. Kurzawa R., Dymek L.: Badania in vivo. [w:] Zarys diagnostyki chorób alergicznych wieku rozwojowego. Bamar, 1996.
32. Pope A., Patterson R., Burge H.: Indoor allrgens: assenssing and controlling adverse health effects. National Academy of Sciences. Washington, National Academy Press, 1993.
33. Salvaggio J, Aukrust L.: Postgraduate course presentations. Mold-induced asthma. J. Allergy Clin. Immunol., 68, 327-346.
34. Bogacka E.: Zespół "chorego budynku" (sick building syndrome). [w:] Astma oskrzelowa i przewlekła obturacyjna choroba płuc. red. T. Plusa, K. Jahnz-Różyk, Medpress, W-wa, 2001, 49-56.
35. Platts-Mills T., Woodfolk J., Vaughan J., Squillace S., Sporik R.: Environmental control. [w:] Asthma link between environment, immunology and the airways. Proceedings of the XVI th World Congress of Asthma, Buenos Aires, 1999. red H. Neffen, C.E. Baena-Cagnani, L. Fabbri, S. Holgate, P.O'Byme. Hogrefe and Huber Publ. Seattle, Toronto, Bern, Gottingen, 1999, 119-128.
36. Katz Y., Verleger H., Barr J., Rachmiel M., Kivit S., Kuttin E.: Indoor survey of moulds and prevalence of mould atopy in Israel. Clin. Exp. Allergy, 1999, 2, 186-192.
37. Perzanowski M.S., Sporik R., Squillace S.P., Gelber L.E., Call R., Carter M.: Association of sensitization to Alternaria allergens with asthma among school-age children. J. Allergy Clin. Immunol. 1998, 5, 626-632.
38. Garret M.H., Garrett M.H., Rayment P.R., Hooper M.A., Abramson M.J., Hooper B.M.: Indoor airborne fungal spores, house dampness and associations with environmental factors and respiratory health in children. Clin. Exp. Allergy, 1998, 4, 459-467.
39. David R.: Nash Pediatric Annals; 1998, 27, 799-808, Medycyna Praktyczna - Pediatria, 1999, 3.
40. Usowska A., Rapiejko P.: Alergiczne zapalenie spojówek. Terapia, 2001, 1, 12-23.
41. Zawisza E., Lipiec A.: Alergeny grzybów. [w:] Choroby alergiczne. red. E. Zawisza, B. Smoliński. PZWL, Warszawa 1998.
42. Tarig S.M., Matthews S.M., Stevens M., Hakim E.A.: Sensitization to Alternaria and Cladosporum by the age of 4 years. Clin. Exp. Allergy, 1996, 26, 794-798.
43. Adamski Z.: Badania nad rola̧ drożdżaków litofilnych Malassezia futur (Pityrosporum ovale, Pityrosporum orbiculare) w różnych dermatozach. Rozprawa habilitacyjna, AM w Poznaniu, 1995.
44. Clemmensen O.J., Hjorth N.: Treatment of atopic dermatitis of the head and Neck with ketoconazole in patients with type I sensitivity to Pityrosporum orbiculare. Semin. Dermatol. 1983, 2, 26-29.
45. Odds F.C.: Pathogenesis of candida infections. J. Am. Acad. Dermatol. 1994, 31, 2-5.
46. Klein P.A., Brook S., Clark R.A.F., Nicol N.H.: Acute infection with Trichophyton rubrum associated with flares of atopic dermatitis. 1999, 118, 192-196.
47. Skov L., Baadsgaard O.: The potential role of Staphylococcus aureus superantigens in atopic dermatitis. J. Eur. Acad. Dermatol. Venerol., 1996, 7, Suppl., 8-11.
48. Rajka G., Barlinn C.: On the significance of the trichophytin reactivity in atopic dermatitis. Acta Dermato-Venereol. 1979, 59, 45-57.
49. Hannifin J.M., Ray L.F., Lobitz W.C.: Immunologic reactivity in dermatophytosis. Br. J. Dermatol., 1974, 90, 1.
50. Wilson B.B., Deuell B., Platts Mills T.A.E.: Atopic dermatitis associated with dermatophyte infection and Trichophyton hypersensitivity. Cutis, 1993, 51, 191-192
51. Hurlimann A., Fah J.: Asthma, rhinitis and dermatitis triggered by fungal infection: Therapeutic effects of terbinafine. Dermatology, 2001, 202, 330-332.
52. James J., Warin R.P.: An assessment of the role of Candida albicans and food yeasts in chronic urticaria. Br. J. Dermatol., 1971, 84, 227-237